Teva Pharmaceuticals commits to Veeva Vault CRM platform globally

Veeva Systems (NYSE: VEEV) announced that Teva Pharmaceuticals has committed to implementing Veeva Vault CRM globally, according to a company statement.

The customer relationship management platform will serve as the technical foundation for Teva's commercial operations. Lavanya Narasimhamurthy, global vice president of IT at Teva, said the move expands the companies' strategic partnership and will support commercial execution.

"We are excited to expand our strategic partnership with Veeva by moving to Vault CRM," Narasimhamurthy stated. "We share a deep commitment to customer success, and Vault CRM will provide Teva the technical foundation to drive commercial execution."

Vault CRM is part of the Vault CRM Suite of applications designed for commercial execution in the pharmaceutical industry. The platform includes the Agentic Call Report feature, which generates commercial evidence using compliant free text to provide insights for commercial operations.

Tom Schwenger, president and chief commercial officer at Veeva, noted Teva's work across neuroscience, immunology, generic medicines, biosimilars, and pharmacy brands. The partnership extension reflects Teva's focus on addressing patient needs, according to Schwenger.

Veeva Systems provides cloud-based software solutions for the life sciences industry, serving more than 1,500 customers ranging from large pharmaceutical companies to emerging biotechnology firms.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• Comfort Systems USA names new COO and Chief Strategy Officer